Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2011 Publisher: Ferring Pharmaceuticals Ltd., Drayton Hall, Church Road, West Drayton, UB7 7PS, United Kingdom
DDAVP/Desmopressin Injection.
| Pharmaceutical Form |
|---|
|
Solution for injection. |
Each 1ml ampoule contains Desmopressin acetate 4 micrograms per ml.
| Active Ingredient | Description | |
|---|---|---|
| Desmopressin |
Desmopressin is a structural analogue of vasopressin in which the antidiuretic activity has been enhanced by the order of 10, while the vasopressor effect has been reduced by the order of 1500. The clinical advantage of this highly changed ratio of antidiuretic to vasopressor effect is that clinically active antidiuretic doses are far below the threshold for a vasopressor effect. |
| List of Excipients |
|---|
|
Sodium Chloride EP |
Carton containing 10 × 1ml clear Type I glass ampoules. Each ampoule contains 1ml of a sterile, clear, colourless solution for injection.
Ferring Pharmaceuticals Ltd., Drayton Hall, Church Road, West Drayton, UB7 7PS, United Kingdom
PL 03194/0002
10th September 1998
| Drug | Countries | |
|---|---|---|
| DDAVP | Brazil, Canada, Ireland, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
